Oric Pharmaceuticals, Inc. - stock earnings
ORIC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -28.3 million USD | ? USD |
| 2023Q3 | -25.5 million USD | ? USD |
| 2023Q2 | -22.9 million USD | ? USD |
| 2023Q1 | -22.0 million USD | ? USD |
| 2022Q4 | -19.6 million USD | ? USD |
| 2022Q3 | -24.0 million USD | ? USD |
| 2022Q2 | -19.9 million USD | ? USD |
| 2022Q1 | -23.1 million USD | ? USD |
| 2021Q4 | -22.8 million USD | ? USD |
| 2021Q3 | -18.4 million USD | ? USD |
| 2021Q2 | -21.0 million USD | ? USD |
| 2021Q1 | -16.5 million USD | ? USD |
| 2020Q4 | -28.3 million USD | ? USD |
| 2020Q3 | -25.5 million USD | ? USD |
| 2020Q2 | -11.0 million USD | ? USD |
| 2020Q1 | -8.9 million USD | ? USD |
| 2019Q4 | -8.4 million USD | ? USD |
| 2019Q3 | -6.5 million USD | ? USD |
| 2019Q2 | -6.0 million USD | ? USD |
| 2019Q1 | -6.0 million USD | ? USD |
ORIC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -100.7 million USD | ? USD |
| 2022 | -91.5 million USD | ? USD |
| 2021 | -77.7 million USD | ? USD |
| 2020 | -97.3 million USD | ? USD |
| 2019 | -25.5 million USD | ? USD |
| 2018 | -21.4 million USD | ? USD |
| 2017 | -22.0 million USD | ? USD |
ORIC
Price: $9.52
52 week price:
Earnings Per Share: -1.96 USD
P/E Ratio: -6.39
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 145300
Market Capitalization: 753.9 million